Ad
related to: companies in phase 3 clinical trials
Search results
Results from the WOW.Com Content Network
Summit Therapeutics is running a pair of phase 3 clinical trials in the U.S. to support ivonescimab's approval in the country. The company is going after an important target: non-small cell lung ...
Obefazimod is currently in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis ("ABTECT program"). 1,200 UC patients across 36 countries in over 600 study sites will take part in the pivotal Phase 3 program that covers North America, Europe, Latin America, and Asia Pacific.
On Dec. 20, Novo announced results from a phase 3 clinical trial surrounding one of its new GLP-1 candidates, ... we’re issuing “Double Down” alerts for three incredible companies, and there ...
For drug development, the clinical phases start with testing for drug safety in a few human subjects, then expand to many study participants (potentially tens of thousands) to determine if the treatment is effective. [1] Clinical research is conducted on drug candidates, vaccine candidates, new medical devices, and new diagnostic assays.
In particular, its lead anti-obesity program, a molecule called survodutide, is in phase 3 clinical trials right now, and it's unique in the sense that no weight-loss drug on the market right now ...
CagriSema entered Phase III clinical trials in 2023. [6] In December 2024, Novo Nordisk announced the results of REDEFINE 1, one of their series of Phase III trials, testing weekly cagrilintide 2.4 mg and semaglutide 2.4 mg individually and together versus placebo in obese or overweight subjects with one or more comorbidities. [7]
The company, in collaboration with its partner Zai Lab, published a readout from a phase 3 clinical trial of its tumor treating fields (TTF) therapy. This treatment, administered in conjunction ...
Genelux Corporation is a publicly traded late clinical-stage company developing a pipeline of next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. The Company’s most advanced product candidate, Olvi-Vec (olvimulogene nanivacirepvec), is a proprietary, modified ...
Ad
related to: companies in phase 3 clinical trials